ExAdEx U.S. patent about core technology officially granted
The United States Patent and Trademark Office has granted a U.S. patent covering the ExAdEx core technology: a major milestone for our intellectual property portfolio and a confirmation of our science-driven approach. A technology built to bridge the gap between preclinical research and human biology At the core of ExAdEx-Innov’s platform is a fundamental […]
GLP-1 agonists and Face Aging: Decoding Effects with Ex Vivo Facial Models
Understanding and countering facial tissue effects with our unique donor ex vivo models The rise of GLP-1 agonists is revolutionizing obesity management, but has revealing a major aesthetic side effect in clinical practice, the so-called « GLP-1 Face » or « Ozempic Face. » At ExAdEx-Innov, we decode these mechanisms using our exclusive ex vivo model of human facial […]
Poster session at Obesity Week 2025 by Resalis Therapeutics
EXADEX-INNOV is excited to announce that Resalis Therapeutics will present preclinical translational data at Obesity Week 2025, including results obtained on our human adipose tissue models Novel Therapy: Targeting miR-22 for Energy Expenditure The poster showcases RES-010, a novel antisense oligonucleotide developed by Resalis Therapeutics to inhibit miR-22, an important post-transcriptional regulator of metabolic pathways in […]
ExAdEx-Innov at the 2025 Nordic Life Science Mission
Our journey as part of the French biotech delegation during the Nordic Biotech Mission, organized by Business France Nordics and Bpifrance in Sweden and Denmark, on October 12-16, 2025 Gothenburg: Nordic Life Science Days 2025 At Nordic Life Science Days 2025 in Gothenburg, our COO Luigi Formicola showcased our innovative platform, connecting with Nordic and […]
ExAdEx-Innov at the L’Oréal Innovation Village at WC13
EXADEX-INNOV Selected for the L’Oréal Innovation Village at WC13, taking place in Rio de Janeiro, August 31-September 4, 2025 ExAdEx-Innov has been selected as one of only five startups worldwide to participate in the prestigious L’Oréal Innovation Village during the 13th World Congress on Alternatives and Animal Use in the Life Sciences (WC13), taking […]